Browse
Submit Data
Databases
API
Help

Dataset Information

29 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-67333

ABSTRACT: Transcriptomics profiling of Alzheimer's disease reveal novel molecular targets

OTHER RELATED OMICS DATASETS IN: PRJNA279526

PROVIDER: E-GEOD-67333 | ExpressionAtlas | 2019-05-14

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Similar Datasets

Homo sapiens

Project description:Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets

| PRJNA279526 | ENA

Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA’s, and Their Targets in Colorectal Cancer Progression

Project description:Molecular pathology of Colorectal Cancer: Investigating the role of novel molecular profiles, microRNA’s and their targets in Colorectal Cancer progression

| 2256398 | ecrin-mdr-crc

Gene expression profiling of classical midgut carcinoid primary tumors and liver metastasis

Project description:We identify genes presenting a specific expression profile in midgut carcinoid cells, primary carcinoids tumors and liver metastasis were gene profiled. Gene expression profiling of classical midgut carcinoid primary tumors and liver metastasis reveal potential novel therapeutic targets and molecular signatures. Keywords: disease state comparison

2008-10-29 | GSE9576 | GEO

Homo sapiens

Project description:Alzheimer's Disease Dataset

| PRJNA209800 | ENA

Homo sapiens

Project description:Cerebellum Alzheimer's Disease

| PRJNA104191 | ENA

Physiological tau interactome in brain and its link to tauopathies_complete submission

Project description:Alzheimer's disease (AD) and most of other tauopathies are incurable neurodegenerative diseases with unpleasant symptoms and consequences. The common hallmark of all these diseases is tau pathology but its connection with disease progress has not been completely understood so far. Therefore, uncovering novel tau interacting partners and pathology affected molecular pathways can reveal the causes of diseases as well as potential targets for development of AD treatment. Despite of large amount of known tau interacting partners, limited number of studies focused on in vivo tau interactions in disease or healthy conditions are available. Here, we applied an in vivo crosslinking approach, capable of capturing weak and transient protein-protein interactions, to a unique transgenic rat model of progressive tau pathology similar to human AD. We have identified 175 potential novel and known tau interacting proteins by MALDI-TOF mass spectrometry. Several of the most promising candidates for potential drug development were selected for validation by coimmunoprecipitation and colocalization experiments in animal and cellular models.

2020-05-07 | PXD018687 | Pride

A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling]

Project description:Human iPS cells with different mutations linked to Alzheimer's Disease were differentiated into neurons and subjected to ribosome profiling to identify Alzheimer's Disease associated changes

2019-08-08 | GSE128344 | GEO

Retinal gene expression changes from post-natal 21 (p21) to p60 during retinal degeneration in RCS rat.

Project description:Molecular mechanisms underlying retinal degeneration are not well characterized including in the widely utilized Royal College of Surgeons (RCS) rat model of retinal degeneration. To better understand molecular pathways driving retinal degeneration we performed mRNA transcriptomics on RCS retinas following the natural progression of the disease. This data can identify novel therapeutic targets for future development.

2024-02-28 | GSE237804 | GEO

Homo sapiens

Project description:Temporal Cortex Alzheimer's Disease

| PRJNA104189 | ENA